Literature DB >> 1850928

Expression of the outer capsid protein VP5 of two bluetongue viruses, and synthesis of chimeric double-shelled virus-like particles using combinations of recombinant baculoviruses.

P T Loudon1, T Hirasawa, S Oldfield, M Murphy, P Roy.   

Abstract

We have previously reported the assembly of virus-like particles (VLPs), consisting of the four major structural proteins of bluetongue virus (BTV), in Spodoptera frugiperda cells coinfected with recombinant baculoviruses (French et al. (1990). J. Virol. 64, 5695-5700). In this paper we report further studies using this system to assemble heterologous VLPs containing the outer capsid proteins (VP2 and VP5) of a range of different BTV serotypes. S. frugiperda cells were coinfected with three recombinant baculoviruses; a dual recombinant expressing VP3 and VP7 (of BTV-17 and -10, respectively) in combination with a single recombinant expressing VP2 of BTV-1, -2, -10, -11, 13, or -17 and an additional single recombinant expressing VP5 of BTV-2, BTV-10, or BTV-13. The resultant VLPs were purified and analyzed by electronmicroscopy, Western immunoblotting, and hemagglutination assays to determine whether double-shelled VLPs had been assembled. In the course of these experiments the VP2 proteins of all six available serotypes were successfully incorporated into VLPs. Particles from two different combinations of chimeric VLPs (having VP2 derived from BTV-1 or that of BTV-17) were used to raise antisera in guinea pigs. Both of these sera showed high neutralizing antibody titers against live BTV, indicating that heterologous VLPs may have potential for use in anti-BTV vaccines.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1850928     DOI: 10.1016/0042-6822(91)90620-q

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

Review 1.  Prospects for improved bluetongue vaccines.

Authors:  Polly Roy; Mark Boyce; Robert Noad
Journal:  Nat Rev Microbiol       Date:  2009-02       Impact factor: 60.633

2.  Development of reverse genetics systems for bluetongue virus: recovery of infectious virus from synthetic RNA transcripts.

Authors:  Mark Boyce; Cristina C P Celma; Polly Roy
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

3.  Synthesis of viruslike particles by expression of the putative capsid protein of Leishmania RNA virus in a recombinant baculovirus expression system.

Authors:  T L Cadd; J L Patterson
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

Review 4.  Bluetongue virus assembly and exit pathways.

Authors:  Polly Roy
Journal:  Adv Virus Res       Date:  2020-09-16       Impact factor: 9.938

Review 5.  Vaccines for viral and parasitic diseases produced with baculovirus vectors.

Authors:  Monique M van Oers
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

Review 6.  Nanoparticle- and Microparticle-Based Vaccines against Orbiviruses of Veterinary Importance.

Authors:  Luis Jiménez-Cabello; Sergio Utrilla-Trigo; Natalia Barreiro-Piñeiro; Tomás Pose-Boirazian; José Martínez-Costas; Alejandro Marín-López; Javier Ortego
Journal:  Vaccines (Basel)       Date:  2022-07-14

7.  Use of bacterial artificial chromosomes in baculovirus research and recombinant protein expression: current trends and future perspectives.

Authors:  Polly Roy; Rob Noad
Journal:  ISRN Microbiol       Date:  2012-09-12

Review 8.  Bluetongue virus capsid assembly and maturation.

Authors:  Bjorn-Patrick Mohl; Polly Roy
Journal:  Viruses       Date:  2014-08-21       Impact factor: 5.048

9.  Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness.

Authors:  Daria A Rutkowska; Nobalanda B Mokoena; Tsepo L Tsekoa; Vusi S Dibakwane; Martha M O'Kennedy
Journal:  BMC Vet Res       Date:  2019-12-03       Impact factor: 2.741

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.